Skip to search formSkip to main contentSkip to account menu

lotrafiban

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2010
2010
Summary.  Background: The integrin αIIbβ3 is the major mediator of platelet aggregation and has, therefore, become an important… 
2004
2004
Controversial results have been reported concerning the ability of fibrinogen receptor antagonists (fibans) to induce… 
2004
2004
Collagen and collagen-related peptide (CRP) activate platelets by interacting with glycoprotein (GP)VI. In addition, collagen… 
2004
2004
Collagen and collagen-related peptide (CRP) activate platelets by interacting with glycoprotein (GP)VI. In addition, collagen… 
2004
2004
Gp IIb/IIIa receptor antagonists are potent antiplatelet agents since they block the final pathway in platelet aggregation… 
2003
2003
We have compared the roles of adenosine diphosphate (ADP), thromboxanes and the integrin alpha(2)beta(1) in the activation of… 
2001
2001
Our objective was to assess the safety, tolerability, pharmacokinetics, and pharmacodynamics of lotrafiban, an oral glycoprotein… 
Review
2000
Review
2000
Platelets play a major role in thrombus formation, as well as in the pathogenesis of atherothrombosis. Inhibition of platelet…